Candidate gene
Marker
| expression of RGS1, TAGAP, TNFSF14, and SH2B3 in peripheral blood mononuclear cells can predict Crohn Disease at least 9 months before the appearance of any clinical and serological signs of the disease |
|
RGS1 expression may be a prognostic marker for risk stratification in multiple myeloma |
|
role of RGS1 as a novel prognostic marker for melanoma given its impact on the survival associated with melanoma |
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | hemopathy | | |
promising target for the development of a new multiple myeloma therapy |
| |